Workshop: The Addictive Potential and Challenges with "Smart Drugs": Nootropics-The Addictive Potential and Challenges with "Smart Drugs": Nootropics

Video Transcription

Video Summary

The video transcript discusses the challenges and addictive potential of nootropics, specifically focusing on the drugs Phenibut, Tyneptine, and Kratom. These drugs are part of a larger family of drugs known as nootropics, which are often used for cognitive enhancement. The transcript highlights the hidden nature of these chemicals and the lack of knowledge about their effects and risks. It also emphasizes the growing popularity of these drugs, particularly among college students, older adults, and those seeking to enhance cognitive function.<br /><br />The transcript then delves into the details of Phenibut, discussing its pharmacological aspects and addictive potential. It explains that Phenibut is a GABA-B agonist and has both GABA-A and dopamine activity, making it a potentially addictive drug. It also notes that Phenibut is often used to self-medicate for social anxiety and insomnia, and can cause euphoria and tolerance at higher doses.<br /><br />The transcript then moves on to discuss Tyneptine, another drug in the nootropic family. It explains that Tyneptine is an atypical tricyclic antidepressant and has mu-opioid properties, making it another potentially addictive drug. It highlights the availability of Tyneptine in gas stations and its use among individuals seeking mood enhancement and energy.<br /><br />Finally, the transcript addresses Kratom, a drug sourced from Southeast Asia. It discusses Kratom's history and cultural significance in Southeast Asia, noting that it is used for pain relief, opioid withdrawal, and as a stimulant. The transcript also mentions the increasing use of Kratom in the United States and its potential therapeutic benefits, but emphasizes the lack of clinical evidence and the need for further research.<br /><br />Overall, the video transcript provides an overview of the challenges and addictive potential of nootropics, particularly Phenibut, Tyneptine, and Kratom. It highlights the lack of knowledge about these drugs and the need for increased awareness and education among healthcare professionals.

Keywords

PETH

Phosphatidyl Ethanol

alcohol use

biomarker

screening

diagnosis

monitoring

recovery

therapeutic alliance

addiction medicine

nootropics

Phenibut

Tyneptine

Kratom

cognitive enhancement

addictive potential

GABA-B agonist

dopamine activity

social anxiety

insomnia

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events